Change in Directorate
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
On 8th October 2025, the Board of Kabra Drugs Ltd approved the appointment of Ms. Ritu Tiwari and Ms. Nikita Sinha as Additional Non-Executive Independent Directors, each for a 5-year term subject to shareholder approval. Both new directors bring backgrounds in company secretarial and compliance work, with 8-10 years of experience each. In the same meeting, the Board accepted the resignations of Mr. Bangalore Venkatakrishnappa Ananth Kumar (Whole-Time / Executive Director) and Mrs. Ananthkumar Shilpa (Non-Executive Independent Director), both citing personal reasons. The resignations and appointments are effective from the same date.
A significant board reshuffle with one executive (KMP-level) director exiting alongside an independent director, while two new independent directors come on board. For shareholders, this is a governance-level event; the simultaneous exit of the Whole-Time Director may raise short-term operational continuity questions until the new independent directors settle in.